Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Eickhoff

Showing results (141-150 of 158) with videos related to

Pageof 16
Sort By:
Research Square|September 18, 2023
TrkB-mediated sustained neuroprotection is sex-specific and ERα dependent in adult mice following neonatal hypoxia ischemiaVishal Chanana, Margaret Hackett, Nazli Deveci, et al.
Investigational New Drugs|October 17, 2014
A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumorsNoelle K LoConte, Albiruni R A Razak, Percy Ivy, et al.
Melanoma Research|May 20, 2024
Administration of intratumoral GD2-directed interleukin-2 immunocytokine and local radiation therapy to activate immune rejection of spontaneous canine melanomaMark R Albertini, Cindy L Zuleger, Erik A Ranheim, et al.
Prostate Cancer and Prostatic Diseases|November 11, 2018
Quantification of bone flare on <sup>18</sup>F-NaF PET/CT in metastatic castration-resistant prostate cancerAmy J Weisman, Stephanie A Harmon, Timothy G Perk, et al.
Plos One|June 16, 2025
Preventing respiratory illness in cerebral palsy: Results of a pilot randomized controlled trialRyan J Coller, Kristina Singh-Verdeflor, Jens Eickhoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology GroupKaci L Osenga, Jacquelyn A Hank, Mark R Albertini, et al.
Cancer Medicine|April 9, 2022
A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782)Ticiana A Leal, Marina N Sharifi, Nancy Chan, et al.
The Journal of Pediatrics|November 30, 2020
Linking Parent Confidence and Hospitalization through Mobile Health: A Multisite Pilot StudyRyan J Coller, Carlos F Lerner, Jay G Berry, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 10, 2021
The Level of Alcohol Consumption in the Prior Year Does Not Impact Clinical Outcomes in Patients With Alcohol-Associated HepatitisJessica A Musto, Jens Eickhoff, Meritxell Ventura-Cots, et al.
Investigational New Drugs|October 12, 2013
A phase I study of vorinostat in combination with bortezomib in patients with advanced malignanciesWilliam R Schelman, Anne M Traynor, Kyle D Holen, et al.
Pageof 16

Showing results (141-150 of 158) with videos related to

Sort By:
Pageof 16
Research Square|September 18, 2023
TrkB-mediated sustained neuroprotection is sex-specific and ERα dependent in adult mice following neonatal hypoxia ischemiaVishal Chanana, Margaret Hackett, Nazli Deveci, et al.
Investigational New Drugs|October 17, 2014
A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumorsNoelle K LoConte, Albiruni R A Razak, Percy Ivy, et al.
Melanoma Research|May 20, 2024
Administration of intratumoral GD2-directed interleukin-2 immunocytokine and local radiation therapy to activate immune rejection of spontaneous canine melanomaMark R Albertini, Cindy L Zuleger, Erik A Ranheim, et al.
Prostate Cancer and Prostatic Diseases|November 11, 2018
Quantification of bone flare on <sup>18</sup>F-NaF PET/CT in metastatic castration-resistant prostate cancerAmy J Weisman, Stephanie A Harmon, Timothy G Perk, et al.
Plos One|June 16, 2025
Preventing respiratory illness in cerebral palsy: Results of a pilot randomized controlled trialRyan J Coller, Kristina Singh-Verdeflor, Jens Eickhoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology GroupKaci L Osenga, Jacquelyn A Hank, Mark R Albertini, et al.
Cancer Medicine|April 9, 2022
A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782)Ticiana A Leal, Marina N Sharifi, Nancy Chan, et al.
The Journal of Pediatrics|November 30, 2020
Linking Parent Confidence and Hospitalization through Mobile Health: A Multisite Pilot StudyRyan J Coller, Carlos F Lerner, Jay G Berry, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 10, 2021
The Level of Alcohol Consumption in the Prior Year Does Not Impact Clinical Outcomes in Patients With Alcohol-Associated HepatitisJessica A Musto, Jens Eickhoff, Meritxell Ventura-Cots, et al.
Investigational New Drugs|October 12, 2013
A phase I study of vorinostat in combination with bortezomib in patients with advanced malignanciesWilliam R Schelman, Anne M Traynor, Kyle D Holen, et al.
Pageof 16